M&A

Capricor Therapeutics (CAPR) Files Form 144 on May 19

Published on 5/19/2026

#CAPR#Form144#securities
Capricor Therapeutics (CAPR) Files Form 144 on May 19

AI Summary

Summarized by AI from the source below

Capricor Therapeutics (CAPR) submitted Form 144 on May 19, indicating the intention to sell shares for a specified amount. This filing is a regulatory requirement for sellers of restricted securities. The document helps investors understand potential selling pressure on the stock. Such transactions may impact trading volumes and share price.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

DT/TMUS Merger Consideration Amid Regulatory Scrutiny
M&A

DT/TMUS Merger Consideration Amid Regulatory Scrutiny

Jul 4

Canfor (CFP) Completes Acquisition of PinkWood Facility
M&A

Canfor (CFP) Completes Acquisition of PinkWood Facility

Jul 3

Ann Wagner Invests in KKR (KKR) Private Equity Amid Stake Sale
M&A

Ann Wagner Invests in KKR (KKR) Private Equity Amid Stake Sale

Jul 3

Gilbert Cisneros Trades Stocks Affecting California's Political Scene
M&A

Gilbert Cisneros Trades Stocks Affecting California's Political Scene

Jul 3